Merrill Downgrades HCA to 'Neutral'

Analyst A.J. Rice also cut his estimates, amid a pending change in Medicare outlier payments

Merrill Lynch downgraded HCA (HCA ) to neutral from buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.